Literature DB >> 10417042

Prolonged opioid antagonism with naloxone in chronic renal failure.

S D Hanes1, M Franklin, D A Kuhl, A S Headley.   

Abstract

Respiratory depression secondary to morphine intoxication occurred in an elderly patient with chronic renal failure (CRF). It was reversed with a continuous infusion of naloxone. Approximately 11 hours after the infusion was discontinued, the patient relapsed into respiratory depression consistent with opioid intoxication. He was rechallenged with a naloxone infusion with resolution of the opioid effects. This case suggests prolonged antagonism of opioid effects inconsistent with naloxone's reported pharmacologic effects. Serum naloxone concentrations measured after the end of the infusion suggest that the drug's pharmacokinetics were significantly altered. Further research is necessary to characterize pharmacokinetic changes that occur in CRF. In the absence of this information, similar patients should be closely monitored for relapse of respiratory depression after naloxone is discontinued.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417042     DOI: 10.1592/phco.19.10.897.31557

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Opiate toxicity in patients with renal failure.

Authors:  B R Conway; D G Fogarty; W E Nelson; C C Doherty
Journal:  BMJ       Date:  2006-02-11

Review 2.  Opioids for chronic pain management in patients with dialysis-dependent kidney failure.

Authors:  William C Becker; Michael J Fischer; Daniel G Tobin; Mark B Lockwood; Paul L Kimmel; Laura M Dember; Nwamaka D Eneanya; Manisha Jhamb; Thomas D Nolin
Journal:  Nat Rev Nephrol       Date:  2021-10-07       Impact factor: 28.314

Review 3.  Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.

Authors:  Hossein Ansari; Leila Kouti
Journal:  Curr Pain Headache Rep       Date:  2016-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.